Forty patients with cervical myelopathy underwent high-resolution computed tomography (CT) with intrathecal administration of metrizamide for evaluation of cervical spinal cord atrophy. Thirty of them showed evidence of either focal atrophic distortion or generalized accentuation of the anatomic surface features of the spinal cord. Patients with a Chiari malformation or syringomyelia were excluded. The characteristic features in cervical spondylosis and canal deformity include flattening of the ventral surface of the cord, central infolding, beaking of the lateral funiculi, and wasting of the dorsal surface of the cord. Patients with motor neuron disease showed a combination of anterolateral and posterolateral atrophy reflecting underlying degeneration of the anterior horn cells and / or corticospinal tracts, respectively. Those with monomelic motor neuron disease had a striking ipsilateral hemiatrophy of the spinal cord. Among those presenting with spastic paraparesis, seven with clinically definite multiple sclerosis showed diffuse atrophy or focal degeneration due to a localized plaque of demyelination. Two cases of cord neoplasm showed atrophy secondary to ascending or descending degeneration of the long tracts.High-resolution computed tomography (CT) with intrathecal metrizamide as a contrast agent has become an increasingly reliable tool in the diagnosis of spinal cord disease. While enlargement of the spinal cord secondary to a neoplasm or syrinx is readily recognizable on iophendylate or air myelography, conventional myelography is misleading in cases of spinal co rd atrophy. Routine myelographic imaging relies on two perpendicular projections of the spinal canal and its contents, while metrizamide CT produces a clear, nonsuperimposed cross-sectional image of the bony canal , the dural sac opacified with metrizamide , and th e spinal co rd. Metrizamide opacifies the subarachnoid space and fills the fissures and sulci on the surface of the cord , enabling early detection of subtle anatomic deformity and distortion . It is possible with metrizamide CT to detect cord atrophy with preservation of one or both of the sagittal and transverse diameters . We have found it an excellent method for studying subtle deformities of the spinal cord in vivo without the interference of fi xation artifacts such as are encountered in postmortem studies.
Subjects and MethodsForty patients wi th cervica l myelopathy were studi ed with metrizamide CT at our in stituti on during an 18 month period . Fourteen of th em had spond y lotic mye lopathy w ith mye log raphic evid ence of co rd co mpression or spin al ca nal deformil y. El even pati en ts had upper or lower motor neuron disease diagnosed c linicall y and co nfirmed by elec tro myog raphy. El even presented w ith spastic paraparesis or quad rip aresis; seven of th ese had c linica ll y definite multiple sc lerosis with oli goc lonal bands in th e cereb rospin al flui d, wh il e th e other four had probable multiple sclerosis. The seri es also in c lu ded two cases of co ...